Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 3Synovial Cyst 1Spondylosis 1Spondylolisthesis 1Spinal Stenosis 1Radiculopathy 1Pilonidal Sinus 1Neoplasms 1Musculoskeletal Diseases 1Malignant Neoplasms of Male Genital Organs 1Intervertebral Disc Displacement 1Intervertebral Disc Degeneration 1Hot Flashes 1Carcinoma, Renal Cell 1Agnosia 1

Interventions

Bupivacaine 11Ketamine 9Ropivacaine 8Acetaminophen 8Morphine 7Dexmedetomidine 7Analgesics, Opioid 7Lidocaine 6Anesthesia, General 6Saline Solution 5Fentanyl 5Anesthesia, Local 5Acupuncture Therapy 5parecoxib 4Tramadol 4Surveys and Questionnaires 4Sodium Chloride 4Ethanol 4Analgesia, Epidural 4Transcutaneous Electric Nerve Stimulation 3Radiofrequency Ablation 3Propofol 3Oxycodone 3Ketorolac 3Control Groups 3Anesthetics, Local 3Therapeutics 2Tea 2Pregabalin 2Magnesium Sulfate 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Agnosia × Clonidine × Clear all
NCT07092566 2026-01-20

R.E.C.K vs Exparel in Robotic Nephrectomy

Wake Forest University Health Sciences

Phase 3 Recruiting
170 enrolled
Genitourinary

Agnosia, Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡